Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 5/20 | 0.57 |
| ▸ | POLB | P06746 | 3/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | MYC | P01106 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30177244 | 1.00 | ALDH1A1 (0.67) | ALDH1A1TDP1TSHRHPGDPOLB | |
| Hydrochloric Acid SCHEMBL1373195 | 0.98 | ALDH1A1 (0.64) | ALDH1A1TDP1TSHRHPGDPOLB | |
| SCHEMBL11054997 | 0.98 | ALDH1A1 (0.64) | ALDH1A1TDP1TSHRHPGDPOLB | |
| SCHEMBL11055034 | 0.98 | ALDH1A1 (0.64) | ALDH1A1TDP1TSHRHPGDPOLB | |
| SCHEMBL28476326 | 0.96 | ALDH1A1 (0.62) | ALDH1A1TDP1TSHRHPGDPOLB | |
| Sulfuric Acid SCHEMBL28074092 | 0.93 | ALDH1A1 (0.58) | ALDH1A1TDP1TSHRHPGDPOLB | |
| SCHEMBL9676578 | 0.89 | ALDH1A1 (0.64) | ALDH1A1TDP1TSHRHPGDPOLB | |
| Tetrahydrofuran SCHEMBL29099324 | 0.87 | ALDH1A1 (0.51) | ALDH1A1TDP1TSHRHPGDPOLB | |
| 4-Nitrobenzoic Acid SCHEMBL29051950 | 0.87 | TDP1 (0.62) | ALDH1A1TDP1TSHRHPGDPOLB | |
| SCHEMBL2572950 | 0.87 | ALDH1A1 (0.64) | ALDH1A1TDP1TSHRHPGDPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 950 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707695-A | Method and device for circularly preparing 3-methyl-2-nitrobenzoate compounds | 辽宁优创植物保护有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119392326-B | Electroplating solution and electroplating method, alloy bump and preparation method thereof | 深圳创智芯联科技股份有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119500258-A | Catalyst and method for preparing 3-methyl-2-aminobenzoic acid by continuous catalytic hydrogenation | 西安凯立新材料股份有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119392326-A | Electroplating solution and electroplating method, alloy bump and preparation method thereof | 深圳创智芯联科技股份有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119191986-A | Continuous preparation process of 3-methyl-2-nitrobenzoic acid | 河南羲和化工科技有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-119080334-A | Comprehensive utilization method of nitric acid containing organic matters | 山东友道化学有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-115591514-B | Synthesis device of 3-methyl-2-nitrobenzoic acid | 河南羲和化工科技有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-119019278-A | Method for preparing 2-amino-3-methylbenzamide | 利尔化学股份有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-119019279-A | Method for preparing 2-amino-3-methylbenzamide | 利尔化学股份有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118993919-A | Synthesis method of chlorantraniliprole intermediate K-amine | 湖北泰盛化工有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-101271769-A | Neutral electrolyte for a wet electrolytic capacitor | AVX CORP (US) | 2008-09-24 | — | — | CN | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-6432481-B1 | TRANSFER EFFICIENCY; ADJUSTMENT OF SURFACE TENSION; EJECTION OF INK | SONY CORPORATION (JP) | 2002-08-13 | — | — | US | claimed |
| US-3935005-A | Composition and method for stripping gold and silver | AMERICAN CHEMICAL & REFINING COMPANY, INCORPORATED (US) | 1976-01-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | ALDH1A1 1569/4885TDP1 3338/4885TSHR 2894/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | ALDH1A1 1723/4885TDP1 1182/4885TSHR 4082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.